Clinical Trial Highlights

• 4-T: Treating to Target in Type 2 Diabetes One-Year Results
• Cardiometabolic Risk Related to More than Insulin Resistance
• Parabolic Relationship with Plasma Triglycerides Suggests LDL-Cholesterol Gives Too Little Information
• Elevated HbA1c Associated with Cardiovascular Events in Non-Diabetics
• One-Year Data Show Combination Sitagliptin and Metformin Improves and Sustains Glucose Control in Type 2 Diabetes Compared to Metformin Alone
• Fenofibrate Treatment and Renal Function in Type 2 Diabetes: FIELD Helsinki Substudy
• PREDICTIVE 303: Patient Self-Adjusted Dosing a Safe and Effective Alternative
• MITRE: No Benefit for Continuous Glucose Monitoring Devices